To further investigate the phenotype of A2AR+ CD8+ T cells within tumors, we performed 3’RNA-sequencing on CD8+GFP+ and CD8+GFP− tumor-infiltrating T cells both at baseline and in the context of anti-PD-L1 treatment. The gene discussed is CD8A; the disease is neoplasm.